| Unbound MEDLINE results for: | Bookmark this site | | Articles related to 15725322 [Unique ID], provided by the PubMed system | |
| |
|
| | 1 - 10 of 849 journal articles in the PubMed database | Email to a friend | | |
| Razon Y, Erez E, Vidne B, et al.
Recombinant factor VIIa (NovoSeven) as a hemostatic agent after surgery for congenital heart disease. [Journal Article]
Paediatr Anaesth 2005 Mar; 15(3):235-40.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Pychyńska-Pokorska M, Moll JJ, Krajewski W, et al.
The use of recombinant coagulation factor VIIa in uncontrolled postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass. [Clinical Trial, Journal Article]
Pediatr Crit Care Med 2004 May; 5(3):246-50.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Filsoufi F, Castillo JG, Rahmanian PB, et al.
Effective management of refractory postcardiotomy bleeding with the use of recombinant activated factor VII. [Journal Article]
Ann Thorac Surg 2006 Nov; 82(5):1779-83.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Agarwal HS, Bennett JE, Churchwell KB, et al.
Recombinant factor seven therapy for postoperative bleeding in neonatal and pediatric cardiac surgery. [Journal Article, Research Support, Non-U.S. Gov't]
Ann Thorac Surg 2007 Jul; 84(1):161-8.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Ekert H, Brizard C, Eyers R, et al.
Elective administration in infants of low-dose recombinant activated factor VII (rFVIIa) in cardiopulmonary bypass surgery for congenital heart disease does not shorten time to chest closure or reduce blood loss and need for transfusions: a randomized, double-blind, parallel group, placebo-controlled study of rFVIIa and standard haemostatic replacement therapy versus standard haemostatic replacement therapy. [JOURNAL ARTICLE]
Blood Coagul Fibrinolysis 2006 Jul; 17(5):389-395.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Mitsiakos G, Papaioannou G, Giougi E, et al.
Is the use of rFVIIa safe and effective in bleeding neonates? A retrospective series of 8 cases. [Journal Article]
J Pediatr Hematol Oncol 2007 Mar; 29(3):145-50.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Wittenstein B, Ng C, Ravn H, et al.
Recombinant factor VII for severe bleeding during extracorporeal membrane oxygenation following open heart surgery. [Journal Article]
Pediatr Crit Care Med 2005 Jul; 6(4):473-6.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Dunkley S, Phillips L, McCall P, et al.
Recombinant activated factor VII in cardiac surgery: experience from the Australian and New Zealand Haemostasis Registry. [Journal Article]
Ann Thorac Surg 2008 Mar; 85(3):836-44.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Yilmaz D, Karapinar B, Balkan C, et al.
SINGLE-CENTER EXPERIENCE: Use of Recombinant Factor VIIa for Acute Life-Threatening Bleeding in Children without Congenital Hemorrhagic Disorder. [Journal Article]
Pediatr Hematol Oncol 2008 Jun; 25(4):301-11.
Abstract | Full Citation | Find Related Articles |   |
|
| |
Advertise on this site.
|
